Archived: A Reflection on Current and Future Impurity Challenges – Opportunity or Threat?
Date: 02 July 2019
Time: 16:00 - 17:00 GMT
The talk scrutinised the key impurity challenges examining this across areas as diverse as N-Nitrosamines to Titanium dioxide. Outlining in each case the concerns, current perspective and how as an industry we should look to shape this.
Who should attend? Chemists / Analysts, Quality Assurance professionals, Regulatory Affairs, Directors / VPs with overall accountability
This webinar was presented by Dr Andrew Teasdale, AstraZeneca. Andrew is the author of the ICH Quality Guidelines: An Implementation Guide and tutor on the 2-day course: Practical Management of Impurities and Development of Effective and Comprehensive Control Strategies.